Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 1
1959 1
1962 1
1985 1
1989 1
1990 1
1992 1
1995 2
1996 1
1998 1
1999 4
2000 1
2001 2
2002 4
2003 4
2004 6
2005 2
2006 8
2007 6
2008 3
2009 4
2010 7
2011 5
2012 9
2013 9
2014 8
2015 7
2016 7
2017 6
2018 11
2019 10
2020 6
2021 5
2022 15
2023 17
2024 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Results by year

Filters applied: . Clear all
Page 1
JAK inhibitors to treat STAT3 gain-of-function: a single-center report and literature review.
Atschekzei F, Traidl S, Carlens J, Schütz K, von Hardenberg S, Elsayed A, Ernst D, Risser L, Thiele T, Graalmann T, Raab J, Baumann U, Witte T, Sogkas G. Atschekzei F, et al. Among authors: schutz k. Front Immunol. 2024 Aug 23;15:1400348. doi: 10.3389/fimmu.2024.1400348. eCollection 2024. Front Immunol. 2024. PMID: 39247195 Free PMC article. Review.
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1.
Aykul S, Huang L, Wang L, Das NM, Reisman S, Ray Y, Zhang Q, Rothman N, Nannuru KC, Kamat V, Brydges S, Troncone L, Johnsen L, Yu PB, Fazio S, Lees-Shepard J, Schutz K, Murphy AJ, Economides AN, Idone V, Hatsell SJ. Aykul S, et al. Among authors: schutz k. J Clin Invest. 2022 Jun 15;132(12):e153792. doi: 10.1172/JCI153792. J Clin Invest. 2022. PMID: 35511419 Free PMC article.
Pulmonary Alveolar Microlithiasis: A novel patient and brief review of the literature.
de Oliveira Mekonnen A, Schwerk N, Schütz K, Schramm L, Dreissig A, Grewendorf S, Sukdolak C, Dopfer C, Auber B, von Hardenberg S, Happle C. de Oliveira Mekonnen A, et al. Among authors: schutz k. Klin Padiatr. 2022 Sep;234(5):317-319. doi: 10.1055/a-1721-2545. Epub 2022 Feb 9. Klin Padiatr. 2022. PMID: 35139546 Review. English.
Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles.
Stahl M, Dohna M, Graeber SY, Sommerburg O, Renz DM, Pallenberg ST, Voskrebenzev A, Schütz K, Hansen G, Doellinger F, Steinke E, Thee S, Röhmel J, Barth S, Rückes-Nilges C, Berges J, Hämmerling S, Wielpütz MO, Naehrlich L, Vogel-Claussen J, Tümmler B, Mall MA, Dittrich AM. Stahl M, et al. Among authors: schutz k. Eur Respir J. 2024 Sep 5;64(3):2400004. doi: 10.1183/13993003.00004-2024. Print 2024 Sep. Eur Respir J. 2024. PMID: 38901883 Free PMC article.
Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis.
Rademacher J, Martin L, Theloe A, Stahl M, Mall MA, Joean O, Fuge J, Hansen G, Welte T, Schütz K, Ringshausen FC, Dittrich AM. Rademacher J, et al. Among authors: schutz k. ERJ Open Res. 2023 Aug 29;9(4):00356-2023. doi: 10.1183/23120541.00356-2023. eCollection 2023 Jul. ERJ Open Res. 2023. PMID: 37650087 Free PMC article.
165 results